Animal studies showed that BMS309403 treatment effectively ameliorated GDM symptoms in C57BL/KsJdb−/+ (db/+) GDM mice model, including improving insulin and glucose metabolism, reducing circulating proinflammatory cytokines, and preventing macrophages infiltration in adipose tissues [139,140]. This evidence concerns the gene INS and gestational diabetes.